These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 975971)

  • 21. Oral contraceptives and nonfatal myocardial infarction.
    Jick H; Dinan B; Rothman KJ
    JAMA; 1978 Apr; 239(14):1403-6. PubMed ID: 204803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral contraceptives, smoking, and other factors in relation to risk of venous thromboembolic disease.
    Petitti DB; Wingerd J; Pellegrin F; Ramcharan S
    Am J Epidemiol; 1978 Dec; 108(6):480-5. PubMed ID: 736027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral contraceptive use and the risk of myocardial infarction.
    Rosenberg L; Palmer JR; Lesko SM; Shapiro S
    Am J Epidemiol; 1990 Jun; 131(6):1009-16. PubMed ID: 2343853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Myocardial infarction and estrogen therapy in premenopausal women.
    Rosenberg L; Armstrong B; Jick H
    N Engl J Med; 1976 Jun; 294(23):1290-1. PubMed ID: 1264157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myocardial infarction and oral contraceptives].
    Bounhoure JP; Galinier M; Roncalli J; Assoun B; Puel J
    Bull Acad Natl Med; 2008 Mar; 192(3):569-79; discussion 579. PubMed ID: 18819701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study.
    Dunn NR; Arscott A; Thorogood M
    Contraception; 2001 Feb; 63(2):65-9. PubMed ID: 11292469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of myocardial infarction in young female smokers.
    Dunn NR; Faragher B; Thorogood M; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    Heart; 1999 Nov; 82(5):581-3. PubMed ID: 10525513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myocardial infarction in the young: evolution and clinico-coronarographic correlation (author's transl)].
    Recusani F; De Servi S; Fatica N; Previtali M; Tronconi L; Specchia G
    G Ital Cardiol; 1977; 7(5):441-7. PubMed ID: 873096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risks of oral contraceptive pills.
    Pymar HC; Creinin MD
    Semin Reprod Med; 2001 Dec; 19(4):305-12. PubMed ID: 11727172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral contraceptives and the risk of myocardial infarction.
    Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
    N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial infarction in women.
    Johansson S; Vedin A; Wilhelmsson C
    Epidemiol Rev; 1983; 5():67-95. PubMed ID: 6357823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.
    Karabay CY; Kocabay G; Oduncu V; Kalayci A; Guler A; Karagöz A; Candan O; Basaran O; Zehir R; Izgi A; Esen AM; Kırma C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):387-93. PubMed ID: 23361975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS
    Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction.
    Tanis BC; Bloemenkamp DG; van den Bosch MA; Kemmeren JM; Algra A; van de Graaf Y; Rosendaal FR
    Br J Haematol; 2003 Aug; 122(3):471-8. PubMed ID: 12877676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial infarction in young women with reference to oral contraceptive use.
    Ananijević-Pandey J; Vlajinac H
    Int J Epidemiol; 1989 Sep; 18(3):585-8. PubMed ID: 2807660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M; Mann J; Murphy M; Vessey M
    Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
    Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
    BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cigarette smoking in relation to the risk of myocardial infarction in young women. Modifying influence of age and predisposing factors.
    Rosenberg L; Shapiro S; Kaufman DW; Slone D; Miettinen OS; Stolley PD
    Int J Epidemiol; 1980 Mar; 9(1):57-63. PubMed ID: 7419331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.